Related references
Note: Only part of the references are listed.Molecular classification of IDH-mutant glioblastomas based on gene expression profiles
Fan Wu et al.
CARCINOGENESIS (2019)
A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas
Rui-Chao Chai et al.
MODERN PATHOLOGY (2019)
m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
Rui-Chao Chai et al.
AGING-US (2019)
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
Kosuke Aoki et al.
NEURO-ONCOLOGY (2018)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Mitsuaki Shirahata et al.
ACTA NEUROPATHOLOGICA (2018)
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment
Amelie Griveau et al.
CANCER CELL (2018)
LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer
Kai Zhao et al.
CARCINOGENESIS (2018)
Relapse pathway of glioblastoma revealed by single-cell molecular analysis
Xuelian Chen et al.
CARCINOGENESIS (2018)
A novel prognostic six-CpG signature in glioblastomas
An-An Yin et al.
CNS NEUROSCIENCE & THERAPEUTICS (2018)
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial
Y. Gao et al.
EUROPEAN JOURNAL OF CANCER (2018)
Glioma infiltration and extracellular matrix: key players and modulators
Valeria Pereira Ferrer et al.
GLIA (2018)
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
Allan Lipton et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma
Ruichao Chai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Endothelial trans-differentiation in glioblastoma recurring after radiotherapy
Ivana De Pascalis et al.
MODERN PATHOLOGY (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
Zhengui Zhou et al.
AGING-US (2018)
Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence
Federica Ganci et al.
MODERN PATHOLOGY (2017)
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
Xin Hu et al.
NEURO-ONCOLOGY (2017)
Adult IDH wild-type lower-grade gliomas should be further stratified
Abudumijit Aibaidula et al.
NEURO-ONCOLOGY (2017)
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
Andrea E. Calvert et al.
CELL REPORTS (2017)
Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification
Maarten M. J. Wijnenga et al.
ACTA NEUROPATHOLOGICA (2017)
Tumor Purity as an Underlying Key Factor in Glioma
Chuanbao Zhang et al.
CLINICAL CANCER RESEARCH (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas
Pei Yang et al.
NEURO-ONCOLOGY (2016)
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
Aurelie Kamoun et al.
NATURE COMMUNICATIONS (2016)
Brain tumour cells interconnect to a functional and resistant network
Matthias Osswald et al.
NATURE (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
Zhumei Shi et al.
NEURO-ONCOLOGY (2014)
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA
Yingyu Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
Yongzhi Wang et al.
CANCER LETTERS (2013)
AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries
Rui Chao Chai et al.
GLIA (2013)
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Katherine S. Panageas et al.
NEURO-ONCOLOGY (2012)
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group
Wei Yan et al.
NEURO-ONCOLOGY (2012)
Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma
Soumya A. M. Rao et al.
MODERN PATHOLOGY (2010)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
Predicting survival from microarray data -: a comparative study
H. M. Bovelstad et al.
BIOINFORMATICS (2007)
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
Mathilde C. M. Kouwenhoven et al.
EUROPEAN JOURNAL OF CANCER (2006)
Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling
Bjoern Tews et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Share Paper
